Sgambati TJ

UC Berkeley, Center for the Science of Psychedelics, University of California, Berkeley, Berkeley, USA.

1 paper

ArticlePsychedelics

Well-being as a primary endpoint in clinical trials: a call for consensus.

Marseille E, Kettner H, Sgambati TJ +6

Europe PMC2026